[Essential thrombocythemia. Clinical, biological study and developmental study of 61 cases]. 1984

M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters

The 61 observations of primary thrombocythemia described in this report represent approximately 15% of the cases of polycythemia vera recorded by the authors over the same 18-year period. The group includes 35 females and 26 males, with a mean age of 62. The disease is usually discovered on routine blood tests (half of cases), and more rarely because of hemorrhagic or thrombotic manifestations. Splenomegaly is found in one-third of cases. Platelet count is permanently above 800 X 10(9)/l (mean : 1 500 X 10(9)/l); mild hyperleukocytosis (mean : 16 X 10(9)/l) with predominant neutrophil polynuclears is usual but myelemia is not constant (28% of cases) and always very moderate; red cell parameters are normal in three-fourths of cases, while the remaining patients have anemia, either due to iron depletion or not. Reticulinic myelofibrosis, usually minimal, is found in 40% of cases. Medullary karyotype is always normal, without chromosome Ph1. Platelet functional abnormalities are not constant and do not correlate with the magnitude of thrombocythemia. 51 patients (84%) received myelosuppressive therapy, mainly by busulfan or radioactive phosphorus. Most deaths were due to intercurrent causes and only one patient developed acute leukemia. 71% of patients are alive at five years and subsequent decrease in the actuarial survival curve is very gradual.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010761 Phosphorus Radioisotopes Unstable isotopes of phosphorus that decay or disintegrate emitting radiation. P atoms with atomic weights 28-34 except 31 are radioactive phosphorus isotopes. Radioisotopes, Phosphorus
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D005260 Female Females
D006403 Hematologic Tests Tests used in the analysis of the hemic system. Blood Tests,Hematologic Test,Hematological Tests,Test, Hematologic,Tests, Hematologic,Blood Test,Hematological Test,Test, Blood,Test, Hematological,Tests, Blood,Tests, Hematological
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006918 Hydroxyurea An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxycarbamid,Hydrea,Oncocarbide
D013922 Thrombocytosis Increased numbers of platelets in the peripheral blood. (Dorland, 27th ed) Thrombocythemia,Thrombocythemias,Thrombocytoses
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
June 1988, Cancer,
M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
October 1989, Anales de medicina interna (Madrid, Spain : 1984),
M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
December 1983, Revista medica de Chile,
M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
August 1990, Cancer,
M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
January 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
January 1969, Nouvelle revue francaise d'hematologie,
M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
February 1992, Sangre,
M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
January 1992, Leukemia,
M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
March 1983, Revista clinica espanola,
M Simon, and J P Jouet, and J J Huart, and J L Demory, and F Bauters
June 1991, Haematologica,
Copied contents to your clipboard!